-+ 0.00%
-+ 0.00%
-+ 0.00%

United Therapeutics Director Christopher Patusky Reports Sale of $701,800 in Common Shares

PUBT·11/10/2026 21:46:14
Listen to the news
United Therapeutics Director Christopher Patusky Reports Sale of $701,800 in Common Shares
  • United Therapeutics director Christopher Patusky sold 1,210 common shares at $580 each on November 9, 2026.
  • The sale matched 1,210 shares acquired through stock option exercises at $132.3 per share that day.
  • Following the transactions, Patusky held 2,140 common shares directly, with another 1,100 held indirectly through a trust.
  • His remaining directly held stock options totaled 3,000.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. United Therapeutics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001231427-26-000005), on November 10, 2026, and is solely responsible for the information contained therein.